Rybelsus comes in tablet form
Although uncommon, oral semaglutide can cause some serious health problems
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro, and for chronic weight management as Zepbound
Tirzepatide is generally considered safe for people with cardiovascular risk factors, and weight loss typically improves heart health outcomes
A physician may consider tirzepatide for patients who need medical support for obesity, overweight with weight-related health concerns, insulin resistance, blood sugar concerns, appetite control, or metabolic risk
Semaglutide is a prescription medication used for weight management in adults with a body mass index (BMI) of 30 or greater (obesity) or 27 or greater (overweight) who also have at least one weight-related health condition